Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation. [electronic resource] by
- Nagler, Arnon
- Berger, Raanan
- Ackerstein, Aliza
- Czyz, Jaroslaw A
- Diez-Martin, Jose Luis
- Naparstek, Elizabeth
- Or, Reuven
- Gan, Shlomit
- Shimoni, Avichai
- Slavin, Shimon
Producer: 20100810
In:
Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 33
Availability: No items available.
|
|
|
19.
|
|
|
|
20.
|
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study. [electronic resource] by
- Plimack, Elizabeth R
- Bellmunt, Joaquim
- Gupta, Shilpa
- Berger, Raanan
- Chow, Laura Q M
- Juco, Jonathan
- Lunceford, Jared
- Saraf, Sanatan
- Perini, Rodolfo F
- O'Donnell, Peter H
Producer: 20170605
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|